<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01570998</url>
  </required_header>
  <id_info>
    <org_study_id>117515</org_study_id>
    <secondary_id>NCI-2017-00461</secondary_id>
    <secondary_id>11-06843</secondary_id>
    <secondary_id>117515</secondary_id>
    <secondary_id>P30CA082103</secondary_id>
    <nct_id>NCT01570998</nct_id>
  </id_info>
  <brief_title>Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery</brief_title>
  <official_title>Targeted Intraoperative Radiotherapy United States (TARGIT-US) Phase IV Registry Trial: A Registry Trial of Targeted Intraoperative Radiation Therapy Following Breast-conserving Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This phase IV trial studies the side effects of intraoperative radiation therapy and how well
      it works in treating patients with breast cancer undergoing breast-conserving surgery.
      Delivering radiation one time to the area where the tumor was removed while the patient is
      still in the operating room may kill any residual tumor cells and may be as effective as
      standard radiation therapy in patients with early stage breast cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:

      I. To establish eligibility criteria based on previously published trials and studies in
      order to allow women who meet these criteria to receive intraoperative radiation therapy
      (IORT) on an Institutional Review Board (IRB)-approved protocol.

      II. To systematically collect and assess acute and long-term toxicity and outcomes in larger
      cohort of patients.

      III. To study the efficacy and toxicity of breast radiotherapy given intra-operatively as a
      single fraction after breast conserving surgery, with or without whole breast radiation, as
      indicated by pathologic risk factors, in women with early stage breast cancer.

      IV. In-breast local failure and patterns of in-breast failure. V. Ipsilateral regional nodal
      failure. VI. Toxicity and morbidity. VII. Relapse-free survival. VIII. Overall survival.

      OUTLINE:

      Patients undergo IORT in a single fraction over 15-40 minutes at the time of standard of care
      lumpectomy.

      After completion of study treatment, patients are followed up within 6 weeks and then every 6
      months for 3 years and yearly for 2 years.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of local recurrence</measure>
    <time_frame>Up to 5 years</time_frame>
    <description>Statistical analysis of this study is primarily descriptive and exploratory. An &quot;intent to treat&quot; analysis will be conducted mainly using the log-rank test and Kaplan-Meier to compare hazard rates. Other parametric and nonparametric methods of analysis will also be used.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">750</enrollment>
  <condition>Stage IA Breast Cancer</condition>
  <condition>Stage IIA Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Treatment (IORT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo IORT in a single fraction over 15-40 minutes at the time of standard of care lumpectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Intraoperative Radiation Therapy</intervention_name>
    <description>Undergo IORT</description>
    <arm_group_label>Treatment (IORT)</arm_group_label>
    <other_name>Intraoperative Radiotherapy</other_name>
    <other_name>IORT</other_name>
    <other_name>radiotherapy, intraoperative</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Laboratory Biomarker Analysis</intervention_name>
    <description>Correlative studies</description>
    <arm_group_label>Treatment (IORT)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Suitable for breast conserving surgery

          -  T1 and T2 (&lt; 3.5 cm), N0, M0

        Exclusion Criteria:

          -  Axillary lymph node positive breast cancer

          -  Invasive lobular cancer

          -  Tumor size &gt; 3.5 cm

          -  Extensive intraductal component (EIC &gt;= 25% of the lumpectomy specimen involved with
             ductal carcinoma in situ), as assessed on surgical pathologic lumpectomy specimen

          -  Multicentric cancer in the same breast as diagnosed by clinical examination,
             mammography, ultrasound; magnetic resonance imaging (MRI) or pathologic assessment,
             not amenable to excision with negative margins with a single lumpectomy

          -  Inability to assess pathologic margin status

          -  Synchronous bilateral breast cancer at the time of diagnosis

          -  Ipsilateral breast had a previous cancer and/or prior in-field radiation

          -  Patients known to have BRCA1/2 gene mutations (testing for gene mutations is not
             required)

          -  Patients undergoing primary systemic treatment (hormones or chemotherapy) as initial
             treatment with neoadjuvant reducing tumor size

          -  Previous history of malignant disease does not preclude entry if the expectation of
             relapse-free survival at 10 years or greater

          -  Any factor included as exclusion criteria in the participating center's treatment
             policy statement

          -  Additional exclusion criteria for University of California San Francisco (UCSF) (as
             laid out in the Treatment Policy):

               -  Patients under the age of 50

               -  Estrogen receptor negative (as defined in Treatment Policy under &quot;Pathology&quot;)

               -  HER2 positive (as defined in Treatment Policy under &quot;HER2&quot;)

               -  Lymphovascular invasion

               -  High grade

               -  Tumors &gt; 3 cm

               -  Node positive patients

               -  Prior chemotherapy or hormone therapy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Alvarado</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCSF Medical Center-Mount Zion</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alta Bates Summit Medical Center-Herrick Campus</name>
      <address>
        <city>Berkeley</city>
        <state>California</state>
        <zip>94704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christine S. Chung</last_name>
      <phone>510-204-5311</phone>
      <email>chungc1@sutterhealth.org</email>
    </contact>
    <investigator>
      <last_name>Christine S. Chung</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>California Hospital Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dennis R. Holmes</last_name>
      <phone>213-742-6400</phone>
      <email>dennis.holmes@dignityhealth.org</email>
    </contact>
    <investigator>
      <last_name>Dennis R. Holmes</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UCSF Medical Center-Mount Zion</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael D. Alvarado</last_name>
      <phone>415-353-7111</phone>
    </contact>
    <investigator>
      <last_name>Michael D. Alvarado</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>John Muir Medical Center-Walnut Creek</name>
      <address>
        <city>Walnut Creek</city>
        <state>California</state>
        <zip>94598</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marjaneh Moini</last_name>
      <phone>925-947-3250</phone>
      <email>marjaneh.moini_MD@johnmuirhealth.com</email>
    </contact>
    <investigator>
      <last_name>Marjaneh Moini</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MedStar Georgetown University Hospital</name>
      <address>
        <city>Washington, D.C.</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shawna C. Willey</last_name>
      <phone>202-444-0241</phone>
      <email>scw9@gunet.georgetown.edu</email>
    </contact>
    <investigator>
      <last_name>Shawna C. Willey</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MedStar Washington Hospital Center</name>
      <address>
        <city>Washington, D.C.</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc E. Boisvert</last_name>
      <phone>202-877-7937</phone>
      <email>marc.e.boisvert@medstar.net</email>
    </contact>
    <investigator>
      <last_name>Marc E. Boisvert</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Valente</last_name>
      <phone>216-444-0769</phone>
      <email>valents3@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Stephanie Valente</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Holy Cross Hospital</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joseph J. Casey</last_name>
      <phone>954-772-6700</phone>
      <email>joseph.casey@holy-cross.com</email>
    </contact>
    <investigator>
      <last_name>Joseph J. Casey</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric D. Donnelly</last_name>
      <phone>312-926-4247</phone>
      <email>edonnell@nmff.org</email>
    </contact>
    <investigator>
      <last_name>Eric D. Donnelly</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Small</last_name>
      <phone>708-216-2559</phone>
      <email>wmsamll@lumc.edu</email>
    </contact>
    <investigator>
      <last_name>William Small</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community Cancer Center South</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46227</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan C. Lottich</last_name>
      <phone>317-497-6922</phone>
      <email>greatkarma2006@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Susan C. Lottich</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercy Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neil B. Friedman</last_name>
      <phone>410-332-9330</phone>
      <email>nfriedman@mdmercy.com</email>
    </contact>
    <investigator>
      <last_name>Neil B. Friedman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lahey Hospital and Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca C. Yang</last_name>
      <phone>978-538-4039</phone>
      <email>rebecca.c.yang@lahey.org</email>
    </contact>
    <investigator>
      <last_name>Rebecca C. Yang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community Hospital at Dobbs Ferry</name>
      <address>
        <city>Dobbs Ferry</city>
        <state>New York</state>
        <zip>10522</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pond R. Kelemen</last_name>
      <phone>914-693-5025</phone>
      <email>prkelemen@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Pond R. Kelemen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cornell University</name>
      <address>
        <city>Ithaca</city>
        <state>New York</state>
        <zip>14850-2488</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mary K. Hayes</last_name>
      <phone>212-746-3610</phone>
      <email>mkh2001@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Mary K. Hayes</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University/Herbert Irving Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eileen P. Connolly</last_name>
      <phone>212-305-5547</phone>
      <email>epc2116@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Eileen P. Connolly</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vassar Brothers Medical Center</name>
      <address>
        <city>Poughkeepsie</city>
        <state>New York</state>
        <zip>12601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela J. Keleher</last_name>
      <phone>845-483-6500</phone>
      <email>akeleher@health-quest.org</email>
    </contact>
    <investigator>
      <last_name>Angela J. Keleher</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Hospital-Anderson Campus</name>
      <address>
        <city>Easton</city>
        <state>Pennsylvania</state>
        <zip>18045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lee B. Riley</last_name>
      <phone>484-503-4105</phone>
      <email>rileyl@slhn.org</email>
    </contact>
    <investigator>
      <last_name>Lee B. Riley</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sentara Port Warwick</name>
      <address>
        <city>Newport News</city>
        <state>Virginia</state>
        <zip>23606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Richard A. Hoefer</last_name>
      <phone>757-594-1806</phone>
      <email>rahoefer@sentara.com</email>
    </contact>
    <investigator>
      <last_name>Richard A. Hoefer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aurora BayCare Medical Center</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <zip>54311</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William L. Owens</last_name>
      <phone>920-288-8480</phone>
      <email>william.owens@aurora.org</email>
    </contact>
    <investigator>
      <last_name>William L. Owens</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2012</study_first_submitted>
  <study_first_submitted_qc>April 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2012</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

